Back to Shop
DUAL GLP-1/GIP AGONIST
TIRZEPATIDE
Next-Generation Weight Management
DUAL GLP-1/GIP AGONIST
TIRZEPATIDE
Next-Generation Weight Management
Tirzepatide is a dual GLP-1/GIP receptor agonist representing the next generation of weight management peptides. It targets two key hormonal pathways simultaneously for enhanced results.
KEY BENEFITS
Dual-action GLP-1/GIP receptor agonist
Superior appetite control
Supports significant weight management
May improve metabolic markers
Once-weekly administration
HOW IT WORKS
Tirzepatide works by activating both GLP-1 and GIP receptors, two hormones involved in blood sugar regulation and appetite control. This dual mechanism provides enhanced weight management support compared to single-receptor agonists.
1-Month Supply$399
3-Month Supply$999